Varettoni M - Search Results

1

Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma.

Lazzarino M, Arcaini L, Orlandi E, Iacona I, Bernasconi P, Calatroni S, Varettoni M, Isa L, Brusamolino E, Bonfichi M, Passamonti F, Burcheri S, Pascutto C, Regazzi M. Lazzarino M, et al. Among authors: varettoni m. Oncology. 2005;68(2-3):146-53. doi: 10.1159/000086769. Epub 2005 Jul 4. Oncology. 2005. PMID: 16006752

2

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Visentin A, Chatzikonstantinou T, Scarfò L, Kapetanakis A, Demosthenous C, Karakatsoulis G, Minga E, Chamou D, Allsup D, Cabrero AA, Andres M, Antic D, Baile M, Baliakas P, Besikli-Dimou S, Bron D, Chatzileontiadou S, Cordoba R, Correa JG, Cuéllar-García C, De Paoli L, De Paolis MR, Delgado J, Dimou M, Donaldson D, Catherwood M, Doubek M, Efstathopoulou M, Eichhorst B, Elashwah S, Enrico A, Espinet B, Farina L, Ferrari A, Foglietta M, Frederiksen H, Fürstenau M, García-Marco JA, García-Serra R, Collado R, Gentile M, Gimeno E, Glenthøj A, da Silva MG, Hakobyan YK, Herishanu Y, Hernández-Rivas JÁ, Herold T, Innocenti I, Itchaki G, Jaksic O, Janssens A, Kalashnikova ОB, Kalicińska E, Kater AP, Kersting S, Labrador J, Lad D, Laurenti L, Levin MD, Lista E, Lopez-Garcia A, Malerba L, Marasca R, Marchetti M, Marquet J, Mattsson M, Mauro FR, Morawska M, Motta M, Munir T, Murru R, Niemann CU, Rodrigues RN, Olivieri J, Orsucci L, Papaioannou M, Pavlovsky MA, Piskunova I, Popov VM, Quaglia FM, Quaresmini G, Qvist K, Rigolin GM, Ruchlemer R, Šimkovič M, Špaček M, Sportoletti P, Stanca O, Tadmor T, Capasso A, Del Poeta G, Gutwein O, Karlsson LK, Milosevic I, Mirás F, Reda G, Saghumyan G, Shres… See abstract for full author list ➔ Visentin A, et al. Among authors: varettoni m. Am J Hematol. 2023 Dec;98(12):1856-1868. doi: 10.1002/ajh.27093. Epub 2023 Sep 29. Am J Hematol. 2023. PMID: 37772428 Free article.

3

Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases.

Alessandrino P, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L, Klersy C, Martinelli G, Maiocchi M, Pagnucco G, Varettoni M, Perotti C, Bernasconi C. Alessandrino P, et al. Among authors: varettoni m. Bone Marrow Transplant. 1999 Mar;23(6):533-7. doi: 10.1038/sj.bmt.1701609. Bone Marrow Transplant. 1999. PMID: 10217182

4

Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies.

Alessandrino EP, Bernasconi P, Colombo A, Caldera D, Martinelli G, Vitulo P, Malcovati L, Nascimbene C, Varettoni M, Volpini E, Klersy C, Bernasconi C. Alessandrino EP, et al. Among authors: varettoni m. Bone Marrow Transplant. 2000 Feb;25(3):309-13. doi: 10.1038/sj.bmt.1702154. Bone Marrow Transplant. 2000. PMID: 10673703 Clinical Trial.

5

Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant.

Alessandrino EP, Bernasconi P, Colombo AA, Caldera D, Bonfichi M, Pagnucco G, Malcovati L, Varettoni M, Lazzarino M, Bernasconi C. Alessandrino EP, et al. Among authors: varettoni m. Ann Hematol. 2001 Sep;80(9):521-4. doi: 10.1007/s002770100344. Ann Hematol. 2001. PMID: 11669300

6

Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.

Morra E, Cesana C, Klersy C, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Barbarano L, Lazzarino M; Hematology/Oncology Studies and Trials (HOST) Group, Italy. Morra E, et al. Among authors: varettoni m. Semin Oncol. 2003 Apr;30(2):172-7. doi: 10.1053/sonc.2003.50068. Semin Oncol. 2003. PMID: 12720131

7

First episode of acute hemolysis due to G6PD deficiency in a middle-aged woman and transmission of the enzymatic defect through bone marrow transplant.

Orlandi E, Varettoni M, Bergamaschi G, Lazzarino M. Orlandi E, et al. Among authors: varettoni m. Haematologica. 2004 Apr;89(4):ECR04. Haematologica. 2004. PMID: 15075096 No abstract available.

8

Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone.

Corso A, Lorenzi A, Terulla V, Airò F, Varettoni M, Mangiacavalli S, Zappasodi P, Rusconi C, Lazzarino M. Corso A, et al. Among authors: varettoni m. Ann Hematol. 2004 Sep;83(9):588-91. doi: 10.1007/s00277-004-0891-6. Epub 2004 Jul 3. Ann Hematol. 2004. PMID: 15235749

9

Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.

Morra E, Cesana C, Klersy C, Barbarano L, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Miqueleiz S, Bernuzzi P, Nosari AM, Lazzarino M. Morra E, et al. Among authors: varettoni m. Leukemia. 2004 Sep;18(9):1512-7. doi: 10.1038/sj.leu.2403442. Leukemia. 2004. PMID: 15322559

10

Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal.

Vassallo C, Brazzelli V, Alessandrino PE, Varettoni M, Ardigò M, Lazzarino M, Borroni G. Vassallo C, et al. Among authors: varettoni m. Br J Dermatol. 2004 Sep;151(3):579-86. doi: 10.1111/j.1365-2133.2004.06072.x. Br J Dermatol. 2004. PMID: 15377343

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page